Betazok 23.75 mg Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Prolonged release tablets of metoprolol succinate, (will be referred to as controlled-release tablets, metoprolol CR in the following text).
The metoprolol CR (BETAZOK) 23.75 mg (contains 23.75 mg metoprolol succinate) tablet is white to off-white, oval, scored on both sides and marked A/β on one side.
Each tablet of metoprolol controlled-release (CR) contains 23.75 mg of metoprolol succinate corresponding to 25 mg of metoprolol tartrate.
Excipients/Inactive Ingredients: Ethylcellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, microcrystalline cellulose, paraffin, polyethylene glycol, silicon dioxide, sodium stearyl fumarate and titanium dioxide (E 171).

metoprolol

Manufacturer:

AstraZeneca

Distributor:

Zuellig